Found 663 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)
PHASE1Primary trial objective in this single arm trial is to assess the safety an...
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
PHASE2This study is a multicenter, prospective, randomized phase II trial aimed a...
Location
Zhejiang Cancer Hospital
A Combination Study of CAR-T Therapy in r/r B-NHL
PHASE2In registry studies of CAR-T products that have been marketed globally, pat...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
PHASE3This is a randomized, prospective, multicenter, open-label, Phase III clini...
Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer
PHASE1Study to determine the best dose of stereotactic body radiation therapy (SB...
Location
University of Chicago Medical Center
Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy
PHASE2Radiotherapy can activate local and systemic immune responses through a var...
Location
Multiple Locations
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
PHASE2Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Location
Highlands Oncology Group
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
PHASE3This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Location
Henan Cancer Hospital
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
PHASE2This study is a prospective cohort clinical trial that aims to investigate ...
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
PHASE2This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651